ID

16300

Descripción

Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line; ODM derived from: https://clinicaltrials.gov/show/NCT00191854

Link

https://clinicaltrials.gov/show/NCT00191854

Palabras clave

Versiones (1)
  1. 10/7/16 10/7/16 -
Subido en

10 de julio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00191854

Inglés

Eligibility Breast Cancer NCT00191854

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with histological or cytological proven diagnosis of breast cancer
Descripción

woman with diagnosis of breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0678222
stage iv disease
Descripción

Tumor Stage

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1300072
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
Descripción

ECOG

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
patients had to have previously received anthracycline based regimens as a adjuvant therapy or neo-adjuvant chemotherapy and then progressed and developed metastatic disease
Descripción

Previous anthracycline based regimens

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278941
UMLS CUI [2]
C2939420
adequate organ function
Descripción

organ function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy for metastatic disease
Descripción

prior chemotherapy for metastatic disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C2939420
previous radiation therapy is allowed but must not have included whole pelvis radiation
Descripción

whole pelvis radiation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C3827467
known or suspected brain metastasis. serious concomitant disorders that would compromise the safety of the patient or compromise the patient's ability to complete the study, at the discretion of the investigator
Descripción

brain metastasis or serious concomitant disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0439801
UMLS CUI [2,3]
C0009488
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy and immunotherapy (including trastuzumab (herceptin))
Descripción

concurrent tumor therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0920425
peripheral neuropathy of common toxicity criteria (ctc) grade greater than 1. history of significant neurological or mental disorder, including seizures or dementia
Descripción

peripheral neuropathy, neurological or mental disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C0027765
UMLS CUI [3]
C0004936
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00191854

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
woman with diagnosis of breast cancer
Item
female patients with histological or cytological proven diagnosis of breast cancer
boolean
C0079399 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
Tumor Stage
Item
stage iv disease
boolean
C1300072 (UMLS CUI [1])
ECOG
Item
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
boolean
C1520224 (UMLS CUI [1])
Previous anthracycline based regimens
Item
patients had to have previously received anthracycline based regimens as a adjuvant therapy or neo-adjuvant chemotherapy and then progressed and developed metastatic disease
boolean
C0278941 (UMLS CUI [1])
C2939420 (UMLS CUI [2])
organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
prior chemotherapy for metastatic disease
Item
prior chemotherapy for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C2939420 (UMLS CUI [1,2])
whole pelvis radiation
Item
previous radiation therapy is allowed but must not have included whole pelvis radiation
boolean
C1522449 (UMLS CUI [1,1])
C3827467 (UMLS CUI [1,2])
brain metastasis or serious concomitant disorders
Item
known or suspected brain metastasis. serious concomitant disorders that would compromise the safety of the patient or compromise the patient's ability to complete the study, at the discretion of the investigator
boolean
C0220650 (UMLS CUI [1])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
concurrent tumor therapy
Item
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy and immunotherapy (including trastuzumab (herceptin))
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
peripheral neuropathy, neurological or mental disorder
Item
peripheral neuropathy of common toxicity criteria (ctc) grade greater than 1. history of significant neurological or mental disorder, including seizures or dementia
boolean
C0031117 (UMLS CUI [1])
C0027765 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial